The British Journal of Cardiology

This site is intended for UK healthcare professionals

BJC_podcast_logo_white
Sign in
LOG IN
Listen or subscribe on

An assessment of new cholesterol targets. Measuring Lp(a): A ‘once in a lifetime’ opportunity

Supported
This educational activity was funded by Novartis Pharmaceuticals UK Ltd; however the British Journal of Cardiology retained full editorial control, including the formulation of the agenda, contents and selection of speakers. The media partners for this activity are the British Journal of Cardiology and GPnotebook.
Dr Julia Kenkre and Dr Holly Morgan explore the role of elevated lipoprotein(a) [Lp(a)] levels in cardiovascular risk, its measurement challenges, clinical implications, and the approach to management.

Share this episode:

Speakers

Dr Holly Morgan, Clinical Lecturer and Interventional Cardiology Fellow, King’s College London
Dr Julia Kenkre, Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust

Learning objectives
  • Why Lp(a) is gaining clinical importance, and how elevated Lp(a) levels can influence cardiovascular risk
  • Best practice for measuring Lp(a) levels including who should be tested and how results can guide management strategies
Video

To view the video version, click here

More episodes

To continue, please confirm that you are a UK healthcare professional.

I am not a UK healthcare professional
I confirm I am a UK healthcare professional
BJC_podcast_white-text

Would you like to receive updates about new podcast episodes by email? (You can unsubscribe at any time)